Topiramate may affect how you think and cause confusion, problems with concentration, attention, memory, or speech
Studies have shown that GLP-1RA affects the key phases by reducing its main cytokines and chemokines, such as TNF, IL-6, IL-10, and IL-12, and MCP-1, leading to a reduced inflammatory state, improved endothelial function, and promoted cholesterol efflux
This strategy can improve patient adherence, as it allows for adjustments in treatment regimens that cater to individual tolerances and preferences
A: Semaglutide activates only the GLP-1 receptor
Mallikarjuna K, Gupta S, Shukla S, Chaurasia S
Tirzepatides glucose-lowering effects may be additive with other medications that affect blood glucose, potentially increasing the risk of hypoglycemia